CorMedix CRMD Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '24 | TTM Q2 '24 | TTM Q1 '24 | ||
|---|---|---|---|---|---|---|
| $181.01M— | $163.06M— | -$46.15M-16.0% | -$53.12M-43.9% | -$50.24M-51.2% | ||
| $218.58M— | $164.66M— | -$50.79M-22.1% | -$58.03M-52.3% | -$54.57M-58.0% | ||
| $193.67M— | $150.14M— | -$50.96M-22.3% | -$58.14M-52.3% | -$54.64M-57.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is CorMedix's revenue?
- CorMedix (CRMD) generated $400.1M in revenue over the trailing twelve months, up 384.6% year over year.
- Is CorMedix profitable?
- CorMedix reported $181.0M in net income over the trailing twelve months, a 45.2% net margin.
- What are CorMedix's profit margins?
- Gross margin is 91.9% and operating margin is 48.4%, with a 45.2% net margin.
- What is CorMedix's earnings per share?
- CorMedix's diluted EPS over the trailing twelve months is $2.04.
- Where does CorMedix's income statement data come from?
- Every line is extracted from CorMedix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
